⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QNRX News
Quoin Pharmaceuticals, Ltd. American Depositary Shares
Form 8-K
sec.gov
QNRX
Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
globenewswire.com
QNRX
Quoin Pharmaceuticals Provides Clinical and Regulatory Update from Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton Syndrome
globenewswire.com
QNRX
Quoin Pharmaceuticals to Announce Corporate Update and Fourth Quarter and Full-Year 2025 Financial Results on Thursday, March 26, 2026
globenewswire.com
QNRX
Form 8-K
sec.gov
QNRX
Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome
globenewswire.com
QNRX
NETHERTON NOW Recognizes Rare Disease Day and Highlights Growing Global Awareness of Netherton Syndrome
globenewswire.com
QNRX
Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome
globenewswire.com
QNRX
Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome
globenewswire.com
QNRX
Qatar Construction Industry Report 2025: Output to Rebound at an AAGR of 4.6% During 2027-2029, Supported by Investments in Renewable Energy, and Water Infrastructure Projects
globenewswire.com
QNRX